Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Integra Lifesciences Holdings (IART) Return on Sales (2017 - 2025)

Integra Lifesciences Holdings' Return on Sales history spans 17 years, with the latest figure at 0.0% for Q4 2025.

  • For Q4 2025, Return on Sales fell 5.0% year-over-year to 0.0%; the TTM value through Dec 2025 reached 0.32%, down 31.0%, while the annual FY2025 figure was 0.32%, 31.0% down from the prior year.
  • Return on Sales for Q4 2025 was 0.0% at Integra Lifesciences Holdings, up from 0.01% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.13% in Q4 2022 and bottomed at 1.16% in Q2 2025.
  • The 5-year median for Return on Sales is 0.05% (2023), against an average of 0.01%.
  • The largest annual shift saw Return on Sales grew 10bps in 2021 before it crashed -114bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 0.11% in 2021, then rose by 19bps to 0.13% in 2022, then tumbled by -62bps to 0.05% in 2023, then fell by -12bps to 0.04% in 2024, then tumbled by -109bps to 0.0% in 2025.
  • Per Business Quant, the three most recent readings for IART's Return on Sales are 0.0% (Q4 2025), 0.01% (Q3 2025), and 1.16% (Q2 2025).